Evidence map›Paper›PMID 34285802›Full record

ArticleAnnals of medicine and surgery (2012)2021

Incidental chronic lymphocytic leukemia diagnosed following radical prostatectomy for prostate cancer: A case report.

Ghassen Tlili, Houssem Ammar, Wiem Majdoub, Sonia Dziri, Waad Farhat, Emir Acacha, Arib Rguez, Khaled Ben Ahmed, Awatef Azzabi, Mehdi Jaidane

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ghassen TliliDepartment of Urology, Sahloul Hospital, Sousse, Tunisia.
Houssem AmmarDepartment of Gastrointestinal Surgery, Sahloul Hospital, Sousse, Tunisia.
Wiem MajdoubDepartment of Anatomopathology, Sahloul Hospital, Sousse, Tunisia.
Sonia DziriDepartment of Nephrology, Sahloul Hospital, Sousse, Tunisia.
Waad FarhatDepartment of Gastrointestinal Surgery, Sahloul Hospital, Sousse, Tunisia.
Emir AcachaDepartment of Urology, Sahloul Hospital, Sousse, Tunisia.
Arib RguezDepartment of Gastrointestinal Surgery, Sahloul Hospital, Sousse, Tunisia.
Khaled Ben AhmedDepartment of Urology, Sahloul Hospital, Sousse, Tunisia.
Awatef AzzabiDepartment of Nephrology, Sahloul Hospital, Sousse, Tunisia.
Mehdi JaidaneDepartment of Urology, Sahloul Hospital, Sousse, Tunisia.
Hôpital Sahloul · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundchronic lymphocytic leukemia (CLL) patients have a high risk of occurrence of secondary cancers. This risk is three times higher for all cancers and eight times higher for skin cancer. The coexistence of CLL and adenocarcinoma of the prostate is rare. CASE PRESENTATION: We report a case of a66-year-old man who underwent radical prostatectomy for prostate carcinoma. The final histopathological diagnosis of Gleason 7 adenocarcinoma of the prostate with incidental Rai stage I chronic lymphocytic leukemia (CLL) was made. No further investigations or treatment was offered due to the age and low disease stage. At the last follow-up of 12 months, the patient is alive, without disease progression for both lymphoma and prostate, with a PSA value of 0.03 ng/ml.

conclusionEarly detection of lymphoma after radical prostatectomy will allow optimal management. The analysis of this link requires, therefore, additional investigations.

Indexed as

Chronic lymphocytic leukemiaProstate carcinomaRadical prostatectomy

Identifiers

PMID34285802
PMCPMC8274301
OpenAlexW3166376871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.